Based on 784 businesses audited.
Genentech has 25.7 points more reputation than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech Reputation: Genentech (kadcyla.com)
Kadcyla.com is a fortress of legal compliance and clinical rigidity, where substance significantly outweighs signal. The site suffers from the typical ‘pharma-template’ malaise, but the density of actual trial data makes it nearly immune to traditional BS. Its only ‘bullshit’ is the mechanical repetition of marketing slogans required to make toxic chemotherapy sound like a ‘journey’.
Medical Devices, Pharma & Biotech Reputation: Genentech (kadcyla.com)
The content perfectly aligns with the Pharma & Biotech category, specifically focusing on oncology treatment for HER2-positive breast cancer. The presence of extensive Safety Information and clinical trial results confirms its classification as a highly regulated medical drug site.
“The low score of 85 reflects the high regulatory burden of pharmaceutical sites, which mandates substance (Safety Information, trial percentages, and specific dosing timelines). Points were only lost for the repetition of the '2-in-1' value proposition across indication pages and a trust theatre flag triggered by the presence of a review count without verified proof links in the metadata. The identity and authority of Genentech are fully supported by robust Organization schema and FDA-compliant disclosures.”